trending Market Intelligence /marketintelligence/en/news-insights/trending/5rlF74lknPn9IPB5Pg2hwA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Centurion Medical recalls devices sold with Teleflex's breathing tubes

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Centurion Medical recalls devices sold with Teleflex's breathing tubes

Centurion Medical Products Corp. is recalling 80 airway kits and 70 components that contain Teleflex Inc.'s flexible tubes used for delivering oxygen to a patient's lungs.

The kits are used for opening a patient's airway, providing ventilation and administering anesthetic gas during a surgical procedure when a patient is under general anesthesia.

Centurion Medical, a Williamston, Mich.-based private healthcare equipment company, is recalling devices distributed between Nov. 28, 2018, and June 5. These devices were packaged together with Teleflex's tubes that are being recalled for a mechanical flaw that disconnects patients from the breathing circuit.

Patients disconnected from the breathing circuit risk low blood oxygen, decrease in vital signs and death. Wayne, Pa.-based Teleflex has received reports of four deaths and 18 injuries associated with disconnection, whereas Centurion Medical has not received any reports or complaints.

The U.S. Food and Drug Administration identified the June 7 recall as a class I, the most serious type of recall.